Rachael Rowswell-Turner, Ph.D.
Affiliations: | 2011 | Microbiology and Immunology | State University of New York, Buffalo, Buffalo, NY, United States |
Area:
ImmunologyGoogle:
"Rachael Rowswell-Turner"Parents
Sign in to add mentorNejat Egilmez | grad student | 2011 | SUNY Buffalo | |
(Chronic Chemoimmunotherapy Achieves Cure of Advanced Spontaneous Mammary Tumors via Persistent Blockade of Post-Therapy Counter-Regulation.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Rowswell-Turner RB, Singh RK, Urh A, et al. (2021) HE4 Overexpression by Ovarian Cancer Promotes a Suppressive Tumor Immune Microenvironment and Enhanced Tumor and Macrophage PD-L1 Expression. Journal of Immunology (Baltimore, Md. : 1950) |
James NE, Emerson JB, Borgstadt AD, et al. (2020) The biomarker HE4 (WFDC2) promotes a pro-angiogenic and immunosuppressive tumor microenvironment via regulation of STAT3 target genes. Scientific Reports. 10: 8558 |
James NE, Oliver MT, Ribeiro JR, et al. (2019) Human Epididymis Secretory Protein 4 (HE4) Compromises Cytotoxic Mononuclear Cells via Inducing Dual Specificity Phosphatase 6. Frontiers in Pharmacology. 10: 216 |
James NE, Cantillo E, Oliver MT, et al. (2018) HE4 suppresses the expression of osteopontin in mononuclear cells and compromises their cytotoxicity against ovarian cancer cells. Clinical and Experimental Immunology |
Egilmez NK, Harden JL, Rowswell-Turner RB. (2012) Chemoimmunotherapy as long-term maintenance therapy for cancer. Oncoimmunology. 1: 563-565 |
Rowswell-Turner RB, Harden JL, Nair RE, et al. (2011) Chronic chemoimmunotherapy achieves cure of spontaneous murine mammary tumors via persistent blockade of posttherapy counter-regulation. Journal of Immunology (Baltimore, Md. : 1950). 187: 4109-18 |
Harden JL, Gu T, Kilinc MO, et al. (2011) Dichotomous effects of IFN-γ on dendritic cell function determine the extent of IL-12-driven antitumor T cell immunity. Journal of Immunology (Baltimore, Md. : 1950). 187: 126-32 |
Gu T, Rowswell-Turner RB, Kilinc MO, et al. (2010) Central role of IFNgamma-indoleamine 2,3-dioxygenase axis in regulation of interleukin-12-mediated antitumor immunity. Cancer Research. 70: 129-38 |
Kilinc MO, Rowswell-Turner RB, Gu T, et al. (2009) Activated CD8+ T-effector/memory cells eliminate CD4+ CD25+ Foxp3+ T-suppressor cells from tumors via FasL mediated apoptosis. Journal of Immunology (Baltimore, Md. : 1950). 183: 7656-60 |